B cell content in the tumor microenvironment is associated with improved survival in stage II lung adenocarcinoma
Cancer Research, 2022
The landmark research of BostonGene underscores the importance of combining innovative multi-platform analytics with cutting-edge software to improve patient outcomes. Explore our scientific publications to learn more.